ϟ
DOI: 10.1245/s10434-007-9389-5
OpenAccess: Closed
This work is not Open Acccess. We may still have a PDF, if this is the case there will be a green box below.
A Randomized Phase 2 Trial of Bevacizumab with or without Daily Low-Dose Interferon Alfa-2b in Metastatic Malignant Melanoma
Kimberly A. Varker,Jennifer E. Biber,Cheryl Kefauver,R. Jensen,Amy Lehman,Donn C. Young,Haifeng Wu,Gregory B. Lesinski,Kari Kendra,Alice Chen,Michael J. Walker,William E. Carson
Medicine
Bevacizumab
Internal medicine
2007
Loading...
- MLA
- APA
- Chicago
- IEEE
- Harvard
- BibTeX
Cite this:
Generate Citation
“A Randomized Phase 2 Trial of Bevacizumab with or without Daily Low-Dose Interferon Alfa-2b in Metastatic Malignant Melanoma” is a paper by Kimberly A. Varker Jennifer E. Biber Cheryl Kefauver R. Jensen Amy Lehman Donn C. Young Haifeng Wu Gregory B. Lesinski Kari Kendra Alice Chen Michael J. Walker William E. Carson published in 2007. It has an Open Access status of “closed”. You can read and download a PDF Full Text of this paper here.